WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totaling 65,100 shares, a decline of 58.1% from the May 31st total of 155,338 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 127,819 shares, the short-interest ratio is currently 0.5 days.

WuXi Biologics (Cayman) Stock Performance

WuXi Biologics (Cayman) stock opened at $8.60 on Monday. WuXi Biologics has a 1-year low of $6.20 and a 1-year high of $11.21. The firm has a 50 day simple moving average of $8.36 and a 200 day simple moving average of $8.92.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.